Sexually transmitted infections (STI) and antenatal care (ANC) clinics in Malawi: effective platforms for improving engagement of men at high HIV risk with voluntary medical male circumcision services.


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
08 2021
Historique:
received: 05 09 2020
revised: 11 11 2020
accepted: 15 11 2020
pubmed: 6 1 2021
medline: 15 12 2021
entrez: 5 1 2021
Statut: ppublish

Résumé

Voluntary medical male circumcision (VMMC), an effective HIV prevention programme for men, is implemented in East and Southern Africa. Approximately 50% of VMMC clients are aged below 15 years. More targeted interventions to reach older men and others at higher short-term HIV risk are needed. We implemented a quality improvement project testing the effectiveness of an active referral-based VMMC recruitment approach, targeting men attending STI clinics and those escorting partners to antenatal care (ANC) clinics, at Bwaila Hospital in Lilongwe, Malawi. We compared the proportions aged older than 15 years among men who received VMMC following referral from STI and ANC clinics with those among men referred from standard community mobilisation. We also analysed referral cascades to VMMC. In total, 330 clients were circumcised after referral from STI (242) and ANC (88) clinics, as compared with 3839 other clients attributed to standard community mobilisation. All clients from ANC and STI clinics were aged over 15 years, as compared with 69% from standard community mobilisation. STI clinics had a higher conversion rate from counselling to VMMC than ANC (12% vs 9%) and a higher contribution to total circumcisions performed at the VMMC clinic (6% vs 2%). Integrating VMMC recruitment and follow-up in STI and ANC clinics co-located with VMMC services can augment demand creation and targeting of men at risk of HIV, based on age and STI history. This approach can be replicated at least in similar health facilities with ANC and STI services in close proximity to VMMC service delivery.

Identifiants

pubmed: 33397801
pii: sextrans-2020-054776
doi: 10.1136/sextrans-2020-054776
pmc: PMC8311083
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

345-350

Subventions

Organisme : PEPFAR
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Reprod Health Matters. 2007 May;15(29):11-4
pubmed: 17512369
PLoS Med. 2014 May 06;11(5):e1001641
pubmed: 24800840
PLoS One. 2019 Mar 18;14(3):e0213605
pubmed: 30883583
PLoS One. 2015 Dec 30;10(12):e0145729
pubmed: 26716442
J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):202-9
pubmed: 16951650
PLoS Med. 2005 Nov;2(11):e298
pubmed: 16231970
Lancet Glob Health. 2017 Nov;5(11):e1113-e1122
pubmed: 29025633
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 4:S292-8
pubmed: 27404011
BMC Public Health. 2014 Oct 30;14:1119
pubmed: 25359662
Hum Resour Health. 2009 Jul 28;7:65
pubmed: 19638222
BMC Med. 2020 Jul 7;18(1):189
pubmed: 32631314
Glob Public Health. 2019 Jan;14(1):91-111
pubmed: 29695201
JAMA. 2014 Aug 20;312(7):703-11
pubmed: 25042290
AIDS. 2017 Apr 24;31(7):1025-1034
pubmed: 28350578
PLoS One. 2014 May 06;9(5):e85051
pubmed: 24802746
Lancet. 2007 Feb 24;369(9562):657-66
pubmed: 17321311
PLoS One. 2014 May 06;9(5):e83998
pubmed: 24802112
Lancet HIV. 2015 May;2(5):e181-9
pubmed: 26120594
AIDS Behav. 2016 Nov;20(11):2503-2513
pubmed: 25931242
Lancet. 2007 Feb 24;369(9562):643-56
pubmed: 17321310
Reprod Health Matters. 2007 May;15(29):57-61
pubmed: 17512376
Lancet Glob Health. 2017 Nov;5(11):e1054-e1055
pubmed: 29025620

Auteurs

Wezi Msungama (W)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.

Geoffrey Menego (G)

HIV and Infectious Disease Unit, Jhpiego, Lilongwe, Malawi.

Frackson Shaba (F)

HIV and Infectious Disease Unit, Jhpiego, Lilongwe, Malawi.

Nicole Flowers (N)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Melissa Habel (M)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Abigail Bonongwe (A)

HIV and Infectious Disease Unit, Jhpiego, Lilongwe, Malawi.

Masford Banda (M)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.

Steven Shire (S)

HIV and Infectious Disease Unit, Jhpiego, Lilongwe, Malawi.

Alice Maida (A)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.

Andrew Auld (A)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.

Sam John Peter Phiri (SJP)

Executive Director, Lighthouse Trust, Lilongwe, Malawi.

Kayira Dumbani (K)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.

Nicole Buono (N)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.

Mishek Luhanga (M)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.

Martin Kapito (M)

Department of HIV and AIDS, Ministry of Health, Lilongwe, Malawi.

Hannah Gibson (H)

HIV and Infectious Disease Unit, Jhpiego, Lilongwe, Malawi.

Catey Laube (C)

HIV and Infectious Disease Unit, Jhpiego, Nairobi, Kenya.

Carlos Toledo (C)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Evelyn Kim (E)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Lilongwe, Malawi.

Stephanie Marie Davis (SM)

Division of Global HIV and Tuberculosis, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA sd135626@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH